Literature DB >> 20428940

Antioxidant-like effects and protective action of transcranial magnetic stimulation in depression caused by olfactory bulbectomy.

Inmaculada Tasset1, René Drucker-Colín, José Peña, Ignacio Jimena, Pedro Montilla, Francisco Javier Medina, Isaac Túnez.   

Abstract

We studied the effects of transcranial magnetic stimulation (TMS, 60 Hz and 0.7 mT for 4 h/day for 14 days) on oxidative and cell damage caused by olfactory bulbectomy (OBX) in Wistar rats. The levels of lipid peroxidation products and caspase-3 were enhanced by OBX, whereas it prompted a reduction in reduced glutathione (GSH) content and antioxidative enzymes activities. The treatment with TMS reverted towards normality the biomarkers indicative of oxidative stress and apoptosis. In conclusion, our data show that TMS induced a protection against cell and oxidative damage induced by OBX, as well as they support the hypothesis that oxidative stress may play an important role in depression.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20428940     DOI： 10.1007/s11064-010-0172-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN： 0364-3190            Impact factor:   3.996


  50 in total

1.  Differentiation of chromaffin cells elicited by ELF MF modifies gene expression pattern.

Authors:  Tatiana Olivares-Bañuelos; Luz Navarro; Alicia González; Rene Drucker-Colín
Journal:  Cell Biol Int       Date:  2004       Impact factor: 3.612

2.  Antidepressant-like effect of liquiritin from Glycyrrhiza uralensis in chronic variable stress induced depression model rats.

Authors:  Zhiyu Zhao; Weixing Wang; Hongzhu Guo; Dongfeng Zhou
Journal:  Behav Brain Res       Date:  2008-07-04       Impact factor: 3.332

3.  Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study.

Authors:  C J Murray; A D Lopez
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

4.  Effects of maintenance electroshock on the oxidative damage parameters in the rat brain.

Authors:  Luciano K Jornada; Gustavo Feier; Tatiana Barichello; Angeles M Vitali; Adalisa Reinke; Elaine C Gavioli; Felipe Dal-Pizzol; João Quevedo
Journal:  Neurochem Res       Date:  2007-03       Impact factor: 3.996

5.  Effects of fluoxetine on ischemic cells and expressions in BDNF and some antioxidants in the gerbil hippocampal CA1 region induced by transient ischemia.

Authors:  Do Hoon Kim; Hua Li; Ki-Yeon Yoo; Bong-Hee Lee; In Koo Hwang; Moo Ho Won
Journal:  Exp Neurol       Date:  2007-01-25       Impact factor: 5.330

6.  Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia.

Authors:  Catarina Freitas; Felipe Fregni; Alvaro Pascual-Leone
Journal:  Schizophr Res       Date:  2009-01-11       Impact factor: 4.939

Review 7.  Anxiolytic effects of transcranial magnetic stimulation--an alternative treatment option in anxiety disorders?

Authors:  Peter Zwanzger; A J Fallgatter; M Zavorotnyy; F Padberg
Journal:  J Neural Transm (Vienna)       Date:  2009-01-10       Impact factor: 3.575

8.  Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients.

Authors:  Piotr Gałecki; Janusz Szemraj; Małgorzata Bieńkiewicz; Krzysztof Zboralski; Elzbieta Gałecka
Journal:  Hum Psychopharmacol       Date:  2009-06       Impact factor: 1.672

9.  Repeated electroconvulsive seizure induces c-Myc down-regulation and Bad inactivation in the rat frontal cortex.

Authors:  Won Je Jeon; Se Hyun Kim; Myoung Suk Seo; Yeni Kim; Ung Gu Kang; Yong-Sung Juhnn; Yong Sik Kim
Journal:  Exp Mol Med       Date:  2008-08-31       Impact factor: 8.718

10.  The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode.

Authors:  Salih Selek; Haluk A Savas; H Serdar Gergerlioglu; Feridun Bulbul; Efkan Uz; Mehmet Yumru
Journal:  J Affect Disord       Date:  2007-09-14       Impact factor: 4.839
View more
  5 in total

1.  Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy.

Authors:  Ankur Jindal; Radhakrishnan Mahesh; Shvetank Bhatt
Journal:  Psychopharmacology (Berl)       Date:  2014-08-15       Impact factor: 4.530

Review 2.  Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action.

Authors:  Ana Muñoz-Jurado; Begoña M Escribano; Javier Caballero-Villarraso; Alberto Galván; Eduardo Agüera; Abel Santamaría; Isaac Túnez
Journal:  Inflammopharmacology       Date:  2022-06-05       Impact factor: 5.093

Review 3.  Translational neuromodulation: approximating human transcranial magnetic stimulation protocols in rats.

Authors:  Andrew M Vahabzadeh-Hagh; Paul A Muller; Roman Gersner; Abraham Zangen; Alexander Rotenberg
Journal:  Neuromodulation       Date:  2012-07-10

4.  High-frequency repetitive transcranial magnetic stimulation for treating moderate traumatic brain injury in rats: A pilot study.

Authors:  Xia Lu; Xinjie Bao; Jiantao Li; Guanghao Zhang; Jian Guan; Yunzhou Gao; Peilin Wu; Zhaohui Zhu; Xiaolin Huo; Renzhi Wang
Journal:  Exp Ther Med       Date:  2017-03-29       Impact factor: 2.447

Review 5.  Multimodal Investigations of Reward Circuitry and Anhedonia in Adolescent Depression.

Authors:  Benjamin A Ely; Tram N B Nguyen; Russell H Tobe; Audrey M Walker; Vilma Gabbay
Journal:  Front Psychiatry       Date:  2021-07-23       Impact factor: 4.157
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.